Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan
2021-12-01 12:03
Binhai New Area to spearhead China's medical industry development
2021-12-01 11:20
Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan
2021-12-01 09:00
Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001
2021-12-01 08:00
Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant
2021-12-01 08:00
Innovent Biologics and Ascentage Pharma Announce the China NMPA Approval for China's First Third-Generation BCR-ABL Inhibitor Olverembatinib for the Treatment of Chronic Myeloid Leukemia
2021-12-01 08:00
Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia
2021-12-01 08:00
EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants
2021-12-01 05:22
Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico's Proprietary End-to-end Artificial Intelligence Platform
2021-12-01 05:00
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results
2021-11-30 22:30
New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care
2021-11-30 22:18
Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease
2021-11-30 21:30
NeoLight Acquires Occular Screening Leader Phoenix Technology Group, Strengthening the Company's Newborn Care Global Strategy
2021-11-30 21:00
Jemincare Announces the Exclusive License of the Kras Inhibitor to HUYABIO
2021-11-30 20:42
George Clinical Applauded by Frost & Sullivan for Improving Clinical Trial Efficiency and Patient-centricity through Impactful, Strategic Partnerships
2021-11-30 20:33
Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of TTK inhibitor, CFI-402257
2021-11-30 20:00
Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant
2021-11-30 19:25
JOYSBIO's SARS-COV-2 Antigen Rapid test detects OMICRON variant
2021-11-30 14:00
ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310
2021-11-30 13:00
Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS® Oral Contraceptive
2021-11-30 09:18
1
313
314
315
316
317
894